Search Results - "Cancer gene therapy"
-
1
Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
Published in Cancer gene therapy (01-02-2021)“…Cancer immunotherapy has revolutionised cancer treatment, with immune checkpoint blockade (ICB) therapy and adoptive cell therapy (ACT) increasingly becoming…”
Get full text
Journal Article -
2
Key chemokines direct migration of immune cells in solid tumors
Published in Cancer gene therapy (01-01-2022)“…Immune cell infiltration into solid tumors, their movement within the tumor microenvironment (TME), and interaction with other immune cells are controlled by…”
Get full text
Journal Article -
3
Cancer-associated fibroblasts: overview, progress, challenges, and directions
Published in Cancer gene therapy (01-09-2021)“…Tumors are one of the main causes of death in humans. The development of safe and effective methods for early diagnosis and treatment of tumors is a difficult…”
Get full text
Journal Article -
4
Interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptotic cancer cell death
Published in Cancer gene therapy (01-02-2021)“…Ferroptosis has become a topic of rapidly growing interest in recent years, and has possible therapy implications in cancer therapy. Although excessive…”
Get full text
Journal Article -
5
Transcription factors in ferroptotic cell death
Published in Cancer gene therapy (01-09-2020)“…Ferroptosis, a form of regulated cell death, is characterized by an excessive degree of iron accumulation and lipid peroxidation. Although it was originally…”
Get full text
Journal Article -
6
Dissecting the functional role of microRNA 21 in osteosarcoma
Published in Cancer gene therapy (01-07-2019)“…Osteosarcoma (OS) is considered to be a malignant bone tumour that mainly affects the long bones, but it is also involved in other bones of the body…”
Get full text
Journal Article -
7
METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway
Published in Cancer gene therapy (01-04-2021)“…Methyltransferase-like 3 (METTL3) functions as an RNA methyltransferase that controls the modification of N (6)-methyladenosine (m6A) to influence the…”
Get full text
Journal Article -
8
The KRAS-G12C inhibitor: activity and resistance
Published in Cancer gene therapy (01-07-2022)“…Although it has long been deemed “undruggable”, with the development of drugs specifically binding the KRAS-G12C mutant protein, clinical trials that directly…”
Get full text
Journal Article -
9
TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials
Published in Cancer gene therapy (01-12-2020)“…Immune checkpoint inhibition (ICI) has revolutionized cancer treatment, and produced durable responses in many cancer types. However, there remains a subset of…”
Get full text
Journal Article -
10
Glioblastoma: exosome and microRNA as novel diagnosis biomarkers
Published in Cancer gene therapy (01-12-2016)“…Glioblastoma (GBM) is known as a tumor type, which arises from astrocytes. Several studies indicated that GBM tumor cells are malignant. This is because of the…”
Get full text
Journal Article -
11
New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles
Published in Cancer gene therapy (01-06-2017)“…Cancer is one of the leading cause of death in the world with the prevalence of >10 million mortalities annually. Current cancer treatments include surgical…”
Get full text
Journal Article -
12
LncRNA SNHG14 promotes inflammatory response induced by cerebral ischemia/reperfusion injury through regulating miR-136-5p /ROCK1
Published in Cancer gene therapy (01-07-2019)“…Recently, long non-coding RNAs (lncRNAs) are considered as critical regulators in pathogenesis progression of cerebral ischemia. In present study, lncRNA-small…”
Get full text
Journal Article -
13
Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer
Published in Cancer gene therapy (01-02-2017)“…The most important biological function of exosomes is their possible use as biomarkers in clinical diagnosis. Compared with biomarkers identified in…”
Get full text
Journal Article -
14
MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer
Published in Cancer gene therapy (01-09-2017)“…MicroRNAs (miRNAs) have been proven to be involved in cell metastasis and angiogenesis by interaction with the target mRNAs. Evidence has been confirmed that…”
Get full text
Journal Article -
15
Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study
Published in Cancer gene therapy (01-08-2022)“…Acute lymphoblastic leukemia (ALL) is a cancer-specific lymphoid cell. Induction and consolidation chemotherapy alone or in combination with different…”
Get full text
Journal Article -
16
LOX-1 and cancer: an indissoluble liaison
Published in Cancer gene therapy (01-11-2021)“…Recently, a strong correlation between metabolic disorders, tumor onset, and progression has been demonstrated, directing new therapeutic strategies on…”
Get full text
Journal Article -
17
Protein post-translational modifications in the regulation of cancer hallmarks
Published in Cancer gene therapy (01-04-2023)“…Posttranslational modifications (PTMs) of proteins, the major mechanism of protein function regulation, play important roles in regulating a variety of…”
Get full text
Journal Article -
18
Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy
Published in Cancer gene therapy (01-06-2022)“…Chimeric antigen receptor (CAR) T-cell therapy is an encouraging and fast-growing platform used for the treatment of various types of tumors in human body…”
Get full text
Journal Article -
19
Emerging role of exosomes as promising diagnostic tool for cancer
Published in Cancer gene therapy (01-06-2020)“…The incidence of cancer is experiencing a steep rise in recent times. A survey report produced by GLOBOCAN 2018 estimates about 18.1 million new cases of…”
Get full text
Journal Article -
20
The V-ATPases in cancer and cell death
Published in Cancer gene therapy (01-11-2022)“…Transmembrane ATPases are membrane-bound enzyme complexes and ion transporters that can be divided into F-, V-, and A-ATPases according to their structure. The…”
Get full text
Journal Article